GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Construction In Progress

LumiraDx (LumiraDx) Construction In Progress : $56.4 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Construction In Progress?

LumiraDx's quarterly construction in progress declined from Dec. 2022 ($53.7 Mil) to Mar. 2023 ($0.0 Mil) but then increased from Mar. 2023 ($0.0 Mil) to Jun. 2023 ($56.4 Mil).

LumiraDx's annual construction in progress increased from Dec. 2020 ($45.9 Mil) to Dec. 2021 ($47.3 Mil) and increased from Dec. 2021 ($47.3 Mil) to Dec. 2022 ($53.7 Mil).


LumiraDx Construction In Progress Historical Data

The historical data trend for LumiraDx's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Construction In Progress Chart

LumiraDx Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Construction In Progress
- 45.87 47.26 53.68

LumiraDx Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.26 - 53.68 - 56.37

LumiraDx Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


LumiraDx (LumiraDx) Business Description

Traded in Other Exchanges
N/A
Address
C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108
LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.